# An Exploratory, Open Label, Single Center Study of [F-18]HX4

> **NCT00606424** · EARLY_PHASE1 · COMPLETED · sponsor: **Siemens Molecular Imaging** · enrollment: 10 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** 20 mCi dose for a 50 kg individual of [F-18]HX4

## Key facts

- **NCT ID:** NCT00606424
- **Lead sponsor:** Siemens Molecular Imaging
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2009-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00606424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00606424, "An Exploratory, Open Label, Single Center Study of [F-18]HX4". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00606424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*